Answers are grounded in this paper and cite their sources.
Evaluation of gene polymorphisms links ICAM-1 and SRD5A1 to symptomatic peripheral artery disease, suggesting potential biomarkers.
The genotype distribution of two gene polymorphisms, previously associated with peripheral artery disease (PAD), has been evaluated in a population of diabetic (DPAD) and non-diabetic (NDPAD) patients affected by symptomatic PAD (stages II-IV). A decreased frequency of the AA genotype of rs5498 (ICAM-1) was observed in the PAD subjects compared to controls but this result did not reach statistical significance (p=0.06 by chi-squared test). On the contrary, a significant increase in the frequency of the GG homozygous genotype of rs248793 (SRD5A1) was observed in the PAD patient group in comparison to controls (p=0.01). These data confirm that the GG genotype of rs248793 in the SRD5A1 gene is significantly associated with symptomatic PAD and show a trend towards a stronger association with the non-diabetic status.
No takes yet. Share an insight, caveat, or question.
Barresi et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: